8,538 research outputs found
The Missing Link: Bayesian Detection and Measurement of Intermediate-Mass Black-Hole Binaries
We perform Bayesian analysis of gravitational-wave signals from non-spinning,
intermediate-mass black-hole binaries (IMBHBs) with observed total mass,
, from to and
mass ratio 1\mbox{--}4 using advanced LIGO and Virgo detectors. We employ
inspiral-merger-ringdown waveform models based on the effective-one-body
formalism and include subleading modes of radiation beyond the leading
mode. The presence of subleading modes increases signal power for inclined
binaries and allows for improved accuracy and precision in measurements of the
masses as well as breaking of extrinsic parameter degeneracies. For low total
masses, , the observed chirp
mass ( being the
symmetric mass ratio) is better measured. In contrast, as increasing power
comes from merger and ringdown, we find that the total mass
has better relative precision than . Indeed, at high
(), the signal resembles a
burst and the measurement thus extracts the dominant frequency of the signal
that depends on . Depending on the binary's inclination, at
signal-to-noise ratio (SNR) of , uncertainties in can be
as large as \sim 20 \mbox{--}25\% while uncertainties in are \sim 50 \mbox{--}60\% in binaries with unequal masses (those
numbers become versus in more symmetric binaries).
Although large, those uncertainties will establish the existence of IMBHs. Our
results show that gravitational-wave observations can offer a unique tool to
observe and understand the formation, evolution and demographics of IMBHs,
which are difficult to observe in the electromagnetic window. (abridged)Comment: 17 pages, 9 figures, 2 tables; updated to reflect published versio
Transition from inspiral to plunge in precessing binaries of spinning black holes
We investigate the non-adiabatic dynamics of spinning black hole binaries by
using an analytical Hamiltonian completed with a radiation-reaction force,
containing spin couplings, which matches the known rates of energy and angular
momentum losses on quasi-circular orbits. We consider both a straightforward
post-Newtonian-expanded Hamiltonian (including spin-dependent terms), and a
version of the resummed post-Newtonian Hamiltonian defined by the Effective
One-Body approach. We focus on the influence of spin terms onto the dynamics
and waveforms. We evaluate the energy and angular momentum released during the
final stage of inspiral and plunge. For an equal-mass binary the energy
released between 40Hz and the frequency beyond which our analytical treatment
becomes unreliable is found to be, when using the more reliable Effective
One-Body dynamics: 0.6% M for anti-aligned maximally spinning black holes, 5% M
for aligned maximally spinning black hole, and 1.8% M for non-spinning
configurations. In confirmation of previous results, we find that, for all
binaries considered, the dimensionless rotation parameter J/E^2 is always
smaller than unity at the end of the inspiral, so that a Kerr black hole can
form right after the inspiral phase. By matching a quasi-normal mode ringdown
to the last reliable stages of the plunge, we construct complete waveforms
approximately describing the gravitational wave signal emitted by the entire
process of coalescence of precessing binaries of spinning black holes.Comment: 31 pages, 7 tables, and 13 figure
Galectin-3. One molecule for an alphabet of diseases, from A to Z
Galectin-3 (Gal-3) regulates basic cellular functions such as cell–cell and cell–matrix interactions, growth, proliferation, differentiation, and inflammation. It is not surprising, therefore, that this protein is involved in the pathogenesis of many relevant human diseases, including cancer, fibrosis, chronic inflammation and scarring affecting many different tissues. The papers published in the literature have progressively increased in number during the last decades, testifying the great interest given to this protein by numerous researchers involved in many different clinical contexts. Considering the crucial role exerted by Gal-3 in many different clinical conditions, Gal-3 is emerging as a new diagnostic, prognostic biomarker and as a new promising therapeutic target. The current review aims to extensively examine the studies published so far on the role of Gal-3 in all the clinical conditions and diseases, listed in alphabetical order, where it was analyzed
- …